{"id":"https://openalex.org/W2001694656","doi":"https://doi.org/10.1159/000132393","title":"Epidermal Growth Factor Receptor-Directed Therapy in Esophageal Cancer","display_name":"Epidermal Growth Factor Receptor-Directed Therapy in Esophageal Cancer","publication_year":2007,"publication_date":"2007-01-01","ids":{"openalex":"https://openalex.org/W2001694656","doi":"https://doi.org/10.1159/000132393","mag":"2001694656","pmid":"https://pubmed.ncbi.nlm.nih.gov/18477853"},"language":"en","primary_location":{"id":"doi:10.1159/000132393","doi":"https://doi.org/10.1159/000132393","is_oa":false,"landing_page_url":"https://doi.org/10.1159/000132393","pdf_url":null,"source":{"id":"https://openalex.org/S198727964","display_name":"Oncology","issn_l":"0030-2414","issn":["0030-2414","1423-0232"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5047251095","display_name":"A. U. Pande","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A.U. Pande","raw_affiliation_strings":["Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA","Roswell Park Cancer Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA","institution_ids":["https://openalex.org/I1292894508"]},{"raw_affiliation_string":"Roswell Park Cancer Institute","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055725897","display_name":"Renuka V. Iyer","orcid":"https://orcid.org/0000-0003-3643-8621","observed_orcids":["https://orcid.org/0000-0003-3643-8621"]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R.V. Iyer","raw_affiliation_strings":["Roswell Park Cancer Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roswell Park Cancer Institute","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":null,"display_name":"A. Rani","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I63190737","display_name":"University at Buffalo, State University of New York","ror":"https://ror.org/01y64my43","country_code":"US","type":"education","lineage":["https://openalex.org/I63190737"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. Rani","raw_affiliation_strings":["SUNY Buffalo"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SUNY Buffalo","institution_ids":["https://openalex.org/I63190737"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110461701","display_name":"S. Maddipatla","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I63190737","display_name":"University at Buffalo, State University of New York","ror":"https://ror.org/01y64my43","country_code":"US","type":"education","lineage":["https://openalex.org/I63190737"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. Maddipatla","raw_affiliation_strings":["SUNY Buffalo"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SUNY Buffalo","institution_ids":["https://openalex.org/I63190737"]}]},{"author_position":"middle","author":{"id":null,"display_name":"G.Y. Yang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"G.Y. Yang","raw_affiliation_strings":["Roswell Park Cancer Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roswell Park Cancer Institute","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053518273","display_name":"Chukwumere E. Nwogu","orcid":"https://orcid.org/0000-0003-4036-7037","observed_orcids":["https://orcid.org/0000-0003-4036-7037"]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C.E. Nwogu","raw_affiliation_strings":["Roswell Park Cancer Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roswell Park Cancer Institute","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041348263","display_name":"Jennifer D. Black","orcid":"https://orcid.org/0000-0001-8813-6604","observed_orcids":["https://orcid.org/0000-0001-8813-6604"]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J.D. Black","raw_affiliation_strings":["Roswell Park Cancer Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roswell Park Cancer Institute","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035002650","display_name":"Charles LeVea","orcid":"https://orcid.org/0000-0001-7443-0968","observed_orcids":["https://orcid.org/0000-0001-7443-0968"]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C.M. Levea","raw_affiliation_strings":["Roswell Park Cancer Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roswell Park Cancer Institute","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5054771911","display_name":"Milind M. Javle","orcid":"https://orcid.org/0000-0001-9158-0941","observed_orcids":["https://orcid.org/0000-0001-9158-0941"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M.M. Javle","raw_affiliation_strings":["University of Texas MD Anderson Cancer Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas MD Anderson Cancer Center","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.5792,"has_fulltext":false,"cited_by_count":33,"citation_normalized_percentile":{"value":0.47955556,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"73","issue":"5-6","first_page":"281","last_page":"289"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10619","display_name":"Esophageal Cancer Research and Treatment","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10619","display_name":"Esophageal Cancer Research and Treatment","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.002199999988079071,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/esophageal-adenocarcinoma","display_name":"esophageal adenocarcinoma","score":0.9950000047683716},{"id":"https://openalex.org/keywords/epidermal-growth-factor-receptor","display_name":"epidermal growth factor receptor","score":0.9789999723434448},{"id":"https://openalex.org/keywords/egfr-inhibitors","display_name":"EGFR inhibitors","score":0.9539999961853027},{"id":"https://openalex.org/keywords/gefitinib","display_name":"gefitinib","score":0.9670000076293945},{"id":"https://openalex.org/keywords/oxaliplatin","display_name":"oxaliplatin","score":0.996999979019165},{"id":"https://openalex.org/keywords/chemoradiotherapy","display_name":"chemoradiotherapy","score":0.968999981880188},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.7770000100135803},{"id":"https://openalex.org/keywords/barrett-s-esophagus","display_name":"Barrett's esophagus","score":0.9449999928474426},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.9620000123977661},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.9580000042915344},{"id":"https://openalex.org/keywords/egfr-overexpression","display_name":"EGFR overexpression","score":0.7459999918937683},{"id":"https://openalex.org/keywords/prognosis","display_name":"prognosis","score":0.38600000739097595}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8118805885314941},{"id":"https://openalex.org/C2780580887","wikidata":"https://www.wikidata.org/wiki/Q417824","display_name":"Gefitinib","level":4,"score":0.8014277219772339},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.7373898029327393},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.6731243133544922},{"id":"https://openalex.org/C2779742542","wikidata":"https://www.wikidata.org/wiki/Q372701","display_name":"Esophageal cancer","level":3,"score":0.631882905960083},{"id":"https://openalex.org/C2780962732","wikidata":"https://www.wikidata.org/wiki/Q422327","display_name":"Oxaliplatin","level":4,"score":0.6191445589065552},{"id":"https://openalex.org/C2778424827","wikidata":"https://www.wikidata.org/wiki/Q5090613","display_name":"Chemoradiotherapy","level":3,"score":0.6001110076904297},{"id":"https://openalex.org/C2777506169","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"EGFR inhibitors","level":4,"score":0.5803364515304565},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5600574016571045},{"id":"https://openalex.org/C2779998722","wikidata":"https://www.wikidata.org/wiki/Q420296","display_name":"Cetuximab","level":4,"score":0.5270445942878723},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.46554386615753174},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4632825255393982},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.4565538763999939},{"id":"https://openalex.org/C2776362946","wikidata":"https://www.wikidata.org/wiki/Q424374","display_name":"Epidermal growth factor","level":3,"score":0.42930880188941956},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.42023757100105286},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.41838058829307556},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.2925005555152893},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.14457929134368896}],"mesh":[{"descriptor_ui":"D000069347","descriptor_name":"Erlotinib Hydrochloride","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077156","descriptor_name":"Gefitinib","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000601","qualifier_name":"surgery","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001471","descriptor_name":"Barrett Esophagus","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D001471","descriptor_name":"Barrett Esophagus","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D004938","descriptor_name":"Esophageal Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004938","descriptor_name":"Esophageal Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D004938","descriptor_name":"Esophageal Neoplasms","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D004938","descriptor_name":"Esophageal Neoplasms","qualifier_ui":"Q000601","qualifier_name":"surgery","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D011799","descriptor_name":"Quinazolines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D015994","descriptor_name":"Incidence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016019","descriptor_name":"Survival Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1159/000132393","doi":"https://doi.org/10.1159/000132393","is_oa":false,"landing_page_url":"https://doi.org/10.1159/000132393","pdf_url":null,"source":{"id":"https://openalex.org/S198727964","display_name":"Oncology","issn_l":"0030-2414","issn":["0030-2414","1423-0232"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology","raw_type":"journal-article"},{"id":"pmid:18477853","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18477853","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":59,"referenced_works":["https://openalex.org/W1518353833","https://openalex.org/W1545263360","https://openalex.org/W1663449764","https://openalex.org/W1923056904","https://openalex.org/W1965329315","https://openalex.org/W1976431241","https://openalex.org/W1977130797","https://openalex.org/W1978013017","https://openalex.org/W2000211133","https://openalex.org/W2012824370","https://openalex.org/W2026003643","https://openalex.org/W2030285422","https://openalex.org/W2035163301","https://openalex.org/W2039616505","https://openalex.org/W2046652065","https://openalex.org/W2049396261","https://openalex.org/W2056643921","https://openalex.org/W2061578348","https://openalex.org/W2072222322","https://openalex.org/W2081951714","https://openalex.org/W2085276131","https://openalex.org/W2094337557","https://openalex.org/W2103384680","https://openalex.org/W2107673483","https://openalex.org/W2111039168","https://openalex.org/W2112750808","https://openalex.org/W2118113452","https://openalex.org/W2120923930","https://openalex.org/W2122129320","https://openalex.org/W2127682381","https://openalex.org/W2127862903","https://openalex.org/W2133106318","https://openalex.org/W2136752280","https://openalex.org/W2136871952","https://openalex.org/W2139236349","https://openalex.org/W2141875256","https://openalex.org/W2142120505","https://openalex.org/W2143536404","https://openalex.org/W2147051615","https://openalex.org/W2148783573","https://openalex.org/W2150932780","https://openalex.org/W2164943801","https://openalex.org/W2170751490","https://openalex.org/W2223139686","https://openalex.org/W2227502406","https://openalex.org/W2271625110","https://openalex.org/W2272178001","https://openalex.org/W2408244426","https://openalex.org/W2413679754","https://openalex.org/W2443861548","https://openalex.org/W2596265735","https://openalex.org/W2601068448","https://openalex.org/W2604520444","https://openalex.org/W2913603375","https://openalex.org/W2992470905","https://openalex.org/W3011249602","https://openalex.org/W3012550319","https://openalex.org/W3150618486","https://openalex.org/W4255683556"],"related_works":["https://openalex.org/W2059766605","https://openalex.org/W1970359868","https://openalex.org/W2315444937","https://openalex.org/W2141875256","https://openalex.org/W3029937147","https://openalex.org/W2013729017","https://openalex.org/W2336398030","https://openalex.org/W2064776982","https://openalex.org/W2117350088","https://openalex.org/W2560051234"],"abstract_inverted_index":{"Esophageal":[0],"adenocarcinoma":[1],"(EAC)":[2],"is":[3,79,106,191],"one":[4,75],"of":[5,16,25,64,87,101,164,188],"the":[6,11,62,85,99,114,185,196],"fastest":[7],"growing":[8],"malignancies":[9],"in":[10,48,56,108,134,155],"US.":[12],"The":[13,67],"long-term":[14],"survival":[15,51],"patients":[17,26],"with":[18,139,143,157],"this":[19,57,160,189,200],"cancer":[20],"remains":[21],"poor;":[22],"only":[23],"25%":[24],"undergoing":[27],"surgical":[28],"excision":[29],"are":[30],"alive":[31],"after":[32],"5":[33],"years.":[34],"Multimodal":[35],"programs":[36],"that":[37,98,170],"incorporate":[38],"radiotherapy,":[39],"chemotherapy":[40],"and":[41,78,94,111,130,167],"surgery":[42],"for":[43,159,181],"localized":[44],"tumors":[45],"may":[46,119],"result":[47,60,133],"a":[49,135],"modest":[50],"advantage.":[52],"However,":[53],"significant":[54],"strides":[55],"disease":[58],"can":[59,172],"from":[61],"inclusion":[63],"targeted":[65],"therapies.":[66],"epidermal":[68],"growth":[69],"factor":[70],"receptor":[71],"(EGFR)":[72],"family":[73,103],"represents":[74],"such":[76],"target":[77],"receiving":[80],"increasing":[81],"attention":[82],"due":[83],"to":[84],"advent":[86],"specific":[88],"inhibitors.":[89],"Studies":[90],"conducted":[91],"by":[92],"us":[93],"others":[95],"have":[96,120],"shown":[97],"overexpression":[100],"EGFR":[102,117,123],"signaling":[104],"intermediates":[105],"common":[107],"Barrett's":[109],"esophagus":[110],"EAC.":[112],"In":[113],"latter":[115],"case,":[116],"expression":[118],"prognostic":[121],"significance.":[122],"inhibitors,":[124],"including":[125],"oral":[126],"tyrosine":[127],"kinase":[128],"inhibitors":[129],"monoclonal":[131],"antibodies,":[132],"synergistic":[136],"antitumor":[137],"effect":[138],"chemotherapeutic":[140],"agents":[141],"or":[142,154],"radiotherapy.":[144],"Therefore,":[145],"several":[146],"ongoing":[147],"studies":[148],"include":[149],"EGFR-directed":[150],"therapy":[151],"either":[152],"alone":[153],"combination":[156,190],"chemoradiotherapy":[158],"disease.":[161],"Our":[162],"study":[163],"gefitinib,":[165],"oxaliplatin":[166],"radiotherapy":[168],"suggested":[169],"gefitinib":[171],"be":[173],"safely":[174],"incorporated":[175],"into":[176],"an":[177],"oxaliplatin-based":[178],"chemoradiation":[179],"program":[180],"esophageal":[182],"cancer,":[183],"although":[184],"clinical":[186],"activity":[187],"modest.":[192],"Herein,":[193],"we":[194],"review":[195],"current":[197],"literature":[198],"on":[199],"subject.":[201]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":5}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}